Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO)

Q: What does CUSIP 019770106 represent in this 13F holders report?

CUSIP 019770106 is the security identifier for ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") in Q4 2021?

168 institutional investors reported ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 019770106

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding: 244,825,714
Total 13F shares: 85,813,394
Share change: -2,255,270
Total reported value: $1,280,601,899
Put/Call ratio: 63%
Price per share: $14.92
Number of holders: 168
Value change: -$105,097,078
Number of buys: 97
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 019770106?
CUSIP 019770106 identifies ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 019770106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALLO - Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	7.6%	18,716,306	$481,009,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	3%	7,271,192	$186,868,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	2.7%	6,695,720	$172,080,000	—	30 Sep 2021	13F
Capital Research Global Investors	13F	Company	2.2%	5,404,294	$138,890,000	—	30 Sep 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.8%	4,338,991	$111,512,000	—	30 Sep 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.5%	3,604,300	$92,631,000	—	30 Sep 2021	13F
Capital International Investors	13F	Company	1.4%	3,534,387	$90,834,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.4%	3,513,316	$90,292,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	1.4%	3,321,800	$85,370,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.3%	3,217,285	$82,684,000	—	30 Sep 2021	13F
Capital World Investors	13F	Company	0.92%	2,246,576	$57,737,000	—	30 Sep 2021	13F
Casdin Capital, LLC	13F	Company	0.86%	2,100,000	$53,970,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.81%	1,979,712	$50,878,000	—	30 Sep 2021	13F
Wildcat Capital Management, LLC	13F	Company	0.7%	1,716,370	$44,111,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.51%	1,260,053	$32,383,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.48%	1,175,996	$30,223,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.43%	1,063,026	$27,319,000	—	30 Sep 2021	13F
Lombard Odier Asset Management (Switzerland) SA	13F	Company	0.37%	914,416	$23,500,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	0.37%	909,250	$23,368,000	—	30 Sep 2021	13F
Woodline Partners LP	13F	Company	0.33%	812,730	$20,887,000	—	30 Sep 2021	13F
HHLR ADVISORS, LTD.	13F	Company	0.33%	800,000	$20,560,000	—	30 Sep 2021	13F
PFM Health Sciences, LP	13F	Company	0.32%	775,819	$19,939,000	—	30 Sep 2021	13F
Sessa Capital IM, L.P.	13F	Company	0.31%	750,000	$19,275,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.29%	713,502	$18,336,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.22%	530,996	$13,647,000	—	30 Sep 2021	13F
Pier Capital, LLC	13F	Company	0.18%	450,182	$11,570,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	445,530	$11,450,000	—	30 Sep 2021	13F
Cerity Partners LLC	13F	Company	0.16%	398,052	$10,230,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.16%	387,941	$9,970,083	—	30 Sep 2021	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.16%	381,830	$9,813,000	—	30 Sep 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.14%	341,155	$8,768,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.13%	318,804	$8,193,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.13%	309,509	$7,954,000	—	30 Sep 2021	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.12%	305,411	$7,922,000	—	30 Sep 2021	13F
Coastal Bridge Advisors, LLC	13F	Company	0.12%	301,240	$7,742,000	—	30 Sep 2021	13F
EATON VANCE MANAGEMENT	13F	Company	0.1%	237,155	$6,095,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	228,623	$5,876,000	—	30 Sep 2021	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.09%	216,082	$5,553,000	—	30 Sep 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	211,589	$5,438,000	—	30 Sep 2021	13F
Capital Group Private Client Services, Inc.	13F	Company	0.07%	175,157	$4,502,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.07%	172,510	$4,434,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.07%	172,000	$4,420,000	—	30 Sep 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.06%	150,000	$3,855,000	—	30 Sep 2021	13F
MACQUARIE GROUP LTD	13F	Company	0.06%	148,329	$3,812,000	—	30 Sep 2021	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.06%	141,057	$3,625,000	—	30 Sep 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.05%	131,281	$3,374,000	—	30 Sep 2021	13F
CITIGROUP INC	13F	Company	0.05%	126,655	$3,255,000	—	30 Sep 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.05%	111,365	$2,862,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	101,623	$2,611,000	—	30 Sep 2021	13F
Mitsubishi UFJ Asset Management Co., Ltd.	13F	Company	0.04%	101,373	$2,605,000	—	30 Sep 2021	13F

Institutional Holders of Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO) as of Q4 2021

As of 31 Dec 2021, Allogene Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALLO) was held by 168 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,813,394 shares. The largest 10 holders included TPG GP A, LLC, VANGUARD GROUP INC, BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, STATE STREET CORP, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, Casdin Capital, LLC, CITADEL ADVISORS LLC, and FMR LLC. This page lists 168 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

165

Q4 2021 holders

168

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.